The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient satisfaction with telehealth as an element of hybrid decentralized clinical trials (DCTs): A cross-sectional study of oncology clinical trial participants.
 
Andrew Parsonson
Research Funding - BeiGene (Inst); DualityBio (Inst); Innovent Biologics (Inst); Jiangsu Hengrui Medicine (Inst); Multitude Therapeutics (Inst)
 
Deme Karikios
Honoraria - Abbvie
Consulting or Advisory Role - MSD; Roche; Takeda
Travel, Accommodations, Expenses - MSD
 
John Park
No Relationships to Disclose
 
Dhanusha Sabanathan
Speakers' Bureau - AstraZeneca; Lilly
Research Funding - DualityBio (Inst); MSD Oncology (Inst)
 
Howard Gurney
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Ipsen; Merck Serono
 
Alison Zhang
Honoraria - Astellas Pharma; AstraZeneca; Bayer; MSD Oncology; Mundipharma; Pfizer (Inst)
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bayer; Janssen Oncology; Merck; Merck Sharp & Dohme; Pfizer
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; MSD Oncology
 
Jenny Gilchrist
No Relationships to Disclose
 
Wei Yen Chan
No Relationships to Disclose
 
Sang Kim
No Relationships to Disclose
 
Wesley Harrison
No Relationships to Disclose
 
Sathya Narayanan
Stock and Other Ownership Interests - Cyclopharm; Race Oncology
 
Frances Boyle
Honoraria - AstraZeneca; Eisai; Gilead Sciences; Lilly; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Roche
Research Funding - Gilead Sciences
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Novartis
(OPTIONAL) Uncompensated Relationships - MBS Action Australia Board Member
 
Annie Lau
No Relationships to Disclose